Cargando…
SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity
In response to COVID-19 pandemic, the Zimbabwe government put in place various rigorous measures to curb the spread of the virus. Although roll-out and access to COVID-19 vaccines in Africa have been slow, the World Health Organization (WHO)-led COVID-19 Vaccines Global Access (COVAX) consortium and...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520422/ https://www.ncbi.nlm.nih.gov/pubmed/34707756 http://dx.doi.org/10.11604/pamj.2021.39.255.30331 |
_version_ | 1784584669459644416 |
---|---|
author | Kouamou, Vinie Matarise, Richard Santos, Elizabeth Dos Elose, Nyasha Manasa, Justen |
author_facet | Kouamou, Vinie Matarise, Richard Santos, Elizabeth Dos Elose, Nyasha Manasa, Justen |
author_sort | Kouamou, Vinie |
collection | PubMed |
description | In response to COVID-19 pandemic, the Zimbabwe government put in place various rigorous measures to curb the spread of the virus. Although roll-out and access to COVID-19 vaccines in Africa have been slow, the World Health Organization (WHO)-led COVID-19 Vaccines Global Access (COVAX) consortium and the African vaccine acquisition task team are striving to provide 720 million doses of COVID-19 vaccines to achieve 60% coverage in Africa by June, 2022. In line with this, the Zimbabwe vaccination programme commenced on the 26(th) February 2021 and as of 9(th) June 2021, approximately, 2.6% of the population have been fully vaccinated in the country. Although the COVID-19 pandemic has crippled the economy and caused significant strain on the public health system, much has been done in the country since the first case was recorded (20(th) March 2020). However, much more needs to be done to finally reach the expected 60% herd immunity by June 2022. |
format | Online Article Text |
id | pubmed-8520422 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The African Field Epidemiology Network |
record_format | MEDLINE/PubMed |
spelling | pubmed-85204222021-10-26 SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity Kouamou, Vinie Matarise, Richard Santos, Elizabeth Dos Elose, Nyasha Manasa, Justen Pan Afr Med J Perspectives In response to COVID-19 pandemic, the Zimbabwe government put in place various rigorous measures to curb the spread of the virus. Although roll-out and access to COVID-19 vaccines in Africa have been slow, the World Health Organization (WHO)-led COVID-19 Vaccines Global Access (COVAX) consortium and the African vaccine acquisition task team are striving to provide 720 million doses of COVID-19 vaccines to achieve 60% coverage in Africa by June, 2022. In line with this, the Zimbabwe vaccination programme commenced on the 26(th) February 2021 and as of 9(th) June 2021, approximately, 2.6% of the population have been fully vaccinated in the country. Although the COVID-19 pandemic has crippled the economy and caused significant strain on the public health system, much has been done in the country since the first case was recorded (20(th) March 2020). However, much more needs to be done to finally reach the expected 60% herd immunity by June 2022. The African Field Epidemiology Network 2021-08-20 /pmc/articles/PMC8520422/ /pubmed/34707756 http://dx.doi.org/10.11604/pamj.2021.39.255.30331 Text en Copyright: Vinie Kouamou et al. https://creativecommons.org/licenses/by/4.0/The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Perspectives Kouamou, Vinie Matarise, Richard Santos, Elizabeth Dos Elose, Nyasha Manasa, Justen SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity |
title | SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity |
title_full | SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity |
title_fullStr | SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity |
title_full_unstemmed | SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity |
title_short | SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity |
title_sort | sars-cov-2 in zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520422/ https://www.ncbi.nlm.nih.gov/pubmed/34707756 http://dx.doi.org/10.11604/pamj.2021.39.255.30331 |
work_keys_str_mv | AT kouamouvinie sarscov2inzimbabwemilestonesandchallengesfacedtowardsachievingtheexpected60herdimmunity AT matariserichard sarscov2inzimbabwemilestonesandchallengesfacedtowardsachievingtheexpected60herdimmunity AT santoselizabethdos sarscov2inzimbabwemilestonesandchallengesfacedtowardsachievingtheexpected60herdimmunity AT elosenyasha sarscov2inzimbabwemilestonesandchallengesfacedtowardsachievingtheexpected60herdimmunity AT manasajusten sarscov2inzimbabwemilestonesandchallengesfacedtowardsachievingtheexpected60herdimmunity |